MedTrace Logo

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

NCT03718364 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-02-18

No results posted yet for this study

Summary

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

Conditions

  • Catheter-based Ablation of Atrial Fibrillation

Interventions

PROCEDURE

catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Michael Kuehne, MD · Cardiology/Electrophysiology, University Hospital Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-01
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03718364 on ClinicalTrials.gov